PHK
AMED

Point72 Hong Kong’s Amedisys AMED Stock Holding History

Point72 Hong Kong’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,221
Closed -$505K – 128
2022
Q3 		$505K Buy
5,221
+2,218
+74% +$264K 0.02% 747
2022
Q2 		$316K Buy
+3,003
New +$384K 0.01% 849
2022
Q1 		– Sell
-2,648
Closed -$429K – 1804
2021
Q4 		$429K Sell
2,648
-4,457
-63% -$716K 0.01% 810
2021
Q3 		$1.06M Buy
7,105
+4,911
+224% +$1.02M 0.03% 716
2021
Q2 		$537K Buy
+2,194
New +$576K 0.02% 901
2020
Q4 		– Sell
-2,801
Closed -$662K – 1691
2020
Q3 		$662K Buy
2,801
+229
+9% +$52.1K 0.07% 256
2020
Q2 		$511K Buy
2,572
+2,357
+1,096% +$440K 0.06% 334
2020
Q1 		$39K Sell
215
-100
-32% -$17.8K 0.02% 401
2019
Q4 		$53K Buy
+315
New +$46.8K 0.01% 672
2019
Q3 		– Sell
-104
Closed -$13K – 978
2019
Q2 		$13K Sell
104
-49
-32% -$5.82K ﹤0.01% 833
2019
Q1 		$19K Buy
+153
New +$19.2K 0.01% 682
2018
Q4 		– Sell
-14
Closed -$2K – 872
2018
Q3 		$2K Buy
+14
New +$1.55K ﹤0.01% 764
2018
Q2 		– Sell
-19
Closed -$1K – 885
2018
Q1 		$1K Sell
19
-290
-94% -$16.5K ﹤0.01% 814
2017
Q4 		$16K Buy
309
+305
+7,625% +$16.1K 0.01% 408
2017
Q3 		$0 Buy
+4
New +$212 ﹤0.01% 783

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Point72 Hong Kong's AMED Position: Q4 2022 in Review

Point72 Hong Kong sold out of Amedisys (AMED) in Q4 2022, closing a stake of 5,221 shares — an estimated $505K sold.

Point72 Hong Kong first reported a position in AMED in Q3 2017 and held it in 15 quarters. The position peaked at $1.06M in Q3 2021. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Point72 Hong Kong reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 5,221 Amedisys shares in Q4 2022, an estimated $505K.
  • Point72 Hong Kong first reported a position in Amedisys in Q3 2017 and held it in 15 quarters.
  • Point72 Hong Kong's Amedisys position peaked at $1.06M in Q3 2021.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Point72 Hong Kong's 13F filing for Q4 2022, filed 14 Feb 2023.